Ms Lora Krishna Crouch, RPH | |
1401 Albright Rd, Rock Hill, SC 29730-6576 | |
(803) 366-3784 | |
(803) 366-7455 |
Full Name | Ms Lora Krishna Crouch |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 1401 Albright Rd, Rock Hill, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053691006 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 9727 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Lora Krishna Crouch, RPH 522 Hallman Dr, Rock Hill, SC 29732-7839 Ph: (803) 448-6006 | Ms Lora Krishna Crouch, RPH 1401 Albright Rd, Rock Hill, SC 29730-6576 Ph: (803) 366-3784 |
News Archive
United Nations relief experts are headed to Sri Lanka to help coordinate the international response to the massive tidal waves that struck the Indian Ocean nation after a series of earthquakes rocked the western coast of Northern Sumatra in Indonesia as well as the Andaman and Nicobar Islands.
The Henry Ford Health System — the largest provider of hospital care in the region — made $60 million last calendar year in spite of a stubborn economy and increasing costs to care for poor and uninsured people, officials announced Thursday. The system's continued success — its eighth consecutive year of financial growth — has made it the largest system in southeast Michigan in revenue and in-patient volume, said Robert Riney, president and chief operating officer for the system.
Canadians newly diagnosed with a life-threatening blood cancer, chronic myeloid leukemia (CML) in chronic phase, now have a new treatment option available to them. Health Canada has granted a notice of compliance with conditions for SPRYCEL (dasatinib) as first-line treatment in patients with chronic phase CML.
ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.
› Verified 5 days ago
Erika Christine Drutis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 222 Herlong Ave S, Rock Hill, SC 29732 Phone: 803-329-1234 | |
Patricia Ann Snider, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1645 Cranium Dr, Rock Hill, SC 29732 Phone: 803-325-2792 | |
Dr. Eddie Lamar Black Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 718 Milton Ave, Rock Hill, SC 29730 Phone: 803-608-0445 | |
Jamie E George, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2000 Celanese Rd, Rock Hill, SC 29732 Phone: 803-980-0095 Fax: 803-980-0098 | |
Kerri Brown Hatcher, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1746 Heckle Blvd, Rock Hill, SC 29732 Phone: 803-366-9400 Fax: 803-817-7696 | |
Dr. Haneen Amjad Muhyeddin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1225 Cherry Rd, Rock Hill, SC 29732 Phone: -- |